• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Artificial Intelligence

Smartphone-based digital ruler achieved high diagnostic performance for strabismus screening

byCheng En Xi
March 3, 2026
in Artificial Intelligence, Ophthalmology
Reading Time: 2 mins read
Patient Basics: Crossed Eyes (Strabismus)
Share on FacebookShare on Twitter

1. Wang and colleagues developed a system that uses deep learning algorithms to analyze cover tests recorded by suspected strabismus patients.

2. The digital platform achieved high sensitivity and specificity for differentiating phoria and tropia from normal ocular alignment.

Evidence Rating Level: 2 (Good)

Study Rundown: Early screening and timely treatment of strabismus are crucial for preventing lifelong ocular misalignment in children. However, traditional diagnostic methods, such as cover tests, require specialized expertise. Wang and colleagues evaluated the feasibility of achieving precise strabismus measurement using a smartphone-based system: Digital Ruler of Strabismus (DRS), which used video recordings to detect strabismus.  A prospective study compared DRS to the manual prism and alternate cover test (PACT) methods. Trained non-specialists conducted the video recording, while an expert also used the PACT method. Three ophthalmologists independently diagnosed ortho, phoria, or tropia for all videos. The main performance metrics were the sensitivity, specificity, and accuracy of strabismus diagnosis. The study found that DRS achieved a sensitivity of 0.974, specificity of 0.938, and accuracy of 0.966 for horizontal strabismus. Similarly, high performance was achieved for eso and exo deviations. The mean difference between the DRS and PACT methods also fell within the clinically acceptable range. This study demonstrated that a smartphone-based system can use video recordings to expand access to strabismus screening in resource-limited settings effectively.

Click here to read the study in NEJM AI

Relevant Reading: Strabismus and Artificial Intelligence App: Optimizing Diagnostic and Accuracy

RELATED REPORTS

Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being

Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

In-Depth [prospective cohort]: DRS automatically quantified the prism diopter (PD) of ocular deviation, identified the type, and made a dynamic evaluation of strabismus from a cover-test video. A prospective multicenter cohort study was conducted to validate its applicability. Participants must be at least three years old, and all videos must meet the predetermined minimum technical requirements. The performance metrics were the sensitivity, specificity, and accuracy of strabismus diagnosis. The performance of DRS was then compared to PACT using the Bland-Altman analysis. A total of 459 videos from 335 patients were included in the study. DRS demonstrated a sensitivity of 0.974 (95% confidence interval (CI), 0.949-0.987), specificity of 0.938 (95% CI, 0.872-0.972), and accuracy of 0.966 (95% CI, 0.943-0.979) for horizontal strabismus. For vertical strabismus, sensitivity was 0.801 (95% CI, 0.752 to 0.831), specificity was 0.725 (95% CI, 0.559 to 0.849), and ACC was 0.789 (95% CI, 0.748 to 0.825). For eso and exo deviations, sensitivity was 0.999 (95% CI, 0.982 to 0.999), specificity was 0.918 (95% CI, 0.832 to 0.963), and accuracy was 0.980 (95% CI, 0.957 to 0.991). Compared to the PACT method, DRS achieved an intraclass correlation coefficient of 0.98 (95% CI, 0.98-0.99) for horizontal deviation. The Bland-Altman analysis showed a mean difference of 1.1 PD and a median 95% limits of agreement of 10.4 PD, which was within the clinically acceptable range. Overall, this study demonstrated that strabismus can be effectively assessed using videos filmed on consumer-grade smartphones, and future studies should explore its integration into existing clinical workflows.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: artificial intelligencemachine based learningmachine learningsmartphonestrabismus
Previous Post

Safety and efficacy profile of first-in-class oral p53 reactivator rezatapopt

Next Post

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being

September 16, 2026
Artificial Intelligence

Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy

September 15, 2026
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Next Post

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Merck and Mayo Clinic launch AI-driven precision medicine lab

Admission may not be needed following sleep apnea surgery

Higher sleep apnea-specific hypoxic burden may predict postoperative cardiovascular complications and mortality in obstructive sleep apnea

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.